Liver Stiffness and Risk of Recurrence after Liver Resection for HCC
نویسندگان
چکیده
Introduction: Liver resection(LR) is a curative treatment for hepatocellular carcinoma(HCC) in selected patients context of organ shortage, but the rate recurrence remains high. Our objective was to propose predictive score after LR, based on preoperative factors. Methods: Retrospective monocentric study including who underwent LR HCC between 2015-2018 with AFP score<2 measurement liver stiffness. Recurrence were defined as appearance imaging confirmed at our tumor board. We developed using Cox univariate regression and multivariate analyzis combination plot, optimal thresholds(ROC curves) tested it validation cohort Bootstrap method. Results: 66 HCC. Median meld 8, 54% had an 0 88% single nodule. After average follow-up 40 months, 45.5%. Four variables significantly impacted risk ROC curves allowed select cut off: age >72 years (95% CI1.02-1.14, p=0.003), stiffness >11.2 kPa CI1.02-1.09, p<0.01), INR >1.2 CI2.42-1563, p<0.01) maximum diameter >2.7cm CI1.57-3.23, p<0.01). By assigning one point per positive item, <2 higher recurrence-free survival than those ≥2 (median DFS: 65 months vs. 44 p<0.0001). Conclusion: have identified 4 factors resection, highlighting role This could assist physicians patient selection LT.
منابع مشابه
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection
Background Early hepatocellular carcinoma (HCC) has a limited prognosis due to recurrence rates of more than 50% after liver resection. Recurrence within two years is believed to be caused by untraceable micro metastases at the time of resection. The objective of this study was to investigate EpCAM-positive circulating tumor cells (CTC) as liquid biomarker to identify patients with high risk of...
متن کاملRecurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
Non-alcoholic fatty liver disease (NAFLD) is emerging as a major health problem worldwide. NAFLD is a continuum of disease ranging from mild liver steatosis to severe steatohepatitis, which will ultimately lead to end-stage liver disease with high morbidity and mortality rates. This disorder is considered as a silent liver disease. The metabolic syndrome and its components are accounted as the ...
متن کاملPredictors of early recurrence after resection of colorectal liver metastases
BACKGROUND Early recurrence after resection of colorectal liver metastases (CLM) is common. Patients at risk of early recurrence may be candidates for enhanced preoperative staging and/or earlier postoperative imaging. The aim of this study was to determine if there are any risk factors that specifically predict early liver-only and systemic recurrence. METHODS Retrospective analysis of prosp...
متن کاملEarly disseminated recurrence after liver resection in solitary hepatocellular carcinoma
Purpose Although few hepatectomy patients develop unexpected early diffuse and multinodular recurrence in the remnant liver, the prognosis in such cases is often dismal. The aim of this study was to evaluate the risk factors of early disseminated multinodular hepatocellular carcinoma (HCC) recurrence within 3 months after liver resection for solitary HCC. Methods Eighty-four patients who were...
متن کاملRisk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis
PURPOSE The aim of this study was to find risk factors for early recurrence (ER) and early death (ED) after liver resection for colorectal cancer liver metastasis (CRCLM). METHODS Between May 1990 and December 2011, 279 patients underwent liver resection for CRCLM at Korea University Medical Center. They were assigned to group ER (recurrence within 6 months after liver resection) or group NER...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hpb
سال: 2022
ISSN: ['1365-182X', '1477-2574']
DOI: https://doi.org/10.1016/j.hpb.2022.05.278